Aarti Drugs Ltd.

BSE: 524348 | NSE: AARTIDRUGS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE767A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aarti Drugs Lt Aarti Drugs Ltd. | BSE 416.55 -7.90 (-1.86%) | NSE 417.30 -4.70 (-1.11%) | Trade | Add

BSE Live

Dec 26, 16:01

416.55 -7.90 (-1.86%)

Volume

AVERAGE VOLUME

5-Day

16,872

10-Day

12,544

30-Day

9,750

20,635

NSE Live

Dec 26, 15:59

417.30 -4.70 (-1.11%)

Volume

AVERAGE VOLUME

5-Day

311,819

10-Day

208,336

30-Day

197,930

159,084

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Aarti Drugs (in Rs. Cr.)	Mar 07	Mar 06
Per Share Ratios
Basic EPS (Rs.)	11.76	11.45
Diluted EPS (Rs.)	11.76	11.45
Cash EPS (Rs.)	23.60	22.61
Book Value [ExclRevalReserve]/Share (Rs.)	85.51	75.12
Book Value [InclRevalReserve]/Share (Rs.)	85.51	75.12
Revenue from Operations/Share (Rs.)	247.24	216.51
PBDIT/Share (Rs.)	35.21	31.45
PBIT/Share (Rs.)	25.06	21.99
PBT/Share (Rs.)	16.14	14.52
Net Profit/Share (Rs.)	12.49	12.19
NP After MI And SOA / Share (Rs.)	11.76	11.45
Profitability Ratios
PBDIT Margin (%)	14.24	14.52
PBIT Margin (%)	10.13	10.15
PBT Margin (%)	6.52	6.70
Net Profit Margin (%)	5.05	5.62
NP After MI And SOA Margin (%)	4.75	5.28
Return on Networth/Equity (%)	13.75	15.24
Return on Capital Employed (%)	4.40	4.63
Return on Assets (%)	3.75	3.64
Total Debt/Equity (X)	1.99	2.16
Asset Turnover Ratio (%)	79.02	68.98
Liquidity Ratios
Current Ratio (X)	3.12	2.31
Quick Ratio (X)	1.96	1.44
Inventory Turnover Ratio (X)	4.64	3.75
Dividend Payout Ratio (NP) (%)	10.20	13.10
Dividend Payout Ratio (CP) (%)	5.24	6.85
Earnings Retention Ratio (%)	89.80	86.90
Cash Earnings Retention Ratio (%)	94.76	93.15
Coverage Ratios
Interest Coverage Ratios (%)	2.81	2.94
Interest Coverage Ratios (Post Tax) (%)	2.81	2.94
Valuation Ratios
Enterprise Value (Cr.)	266.59	286.39
EV/Net Operating Revenue (X)	0.92	1.13
EV/EBITDA (X)	6.47	7.78
MarketCap/Net Operating Revenue (X)	0.25	0.41
Retention Ratios (%)	89.79	86.89
Price/BV (X)	0.73	1.18
Price/Net Operating Revenue	0.25	0.41
Earnings Yield	0.19	0.13